1. Home
  2. ZURA vs TYGO Comparison

ZURA vs TYGO Comparison

Compare ZURA & TYGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZURA
  • TYGO
  • Stock Information
  • Founded
  • ZURA 2022
  • TYGO 2007
  • Country
  • ZURA United States
  • TYGO United States
  • Employees
  • ZURA N/A
  • TYGO N/A
  • Industry
  • ZURA Biotechnology: Biological Products (No Diagnostic Substances)
  • TYGO Semiconductors
  • Sector
  • ZURA Health Care
  • TYGO Technology
  • Exchange
  • ZURA Nasdaq
  • TYGO Nasdaq
  • Market Cap
  • ZURA 137.2M
  • TYGO 116.0M
  • IPO Year
  • ZURA N/A
  • TYGO N/A
  • Fundamental
  • Price
  • ZURA $4.16
  • TYGO $2.67
  • Analyst Decision
  • ZURA Buy
  • TYGO Strong Buy
  • Analyst Count
  • ZURA 9
  • TYGO 1
  • Target Price
  • ZURA $11.00
  • TYGO $6.00
  • AVG Volume (30 Days)
  • ZURA 3.9M
  • TYGO 693.8K
  • Earning Date
  • ZURA 11-06-2025
  • TYGO 11-05-2025
  • Dividend Yield
  • ZURA N/A
  • TYGO N/A
  • EPS Growth
  • ZURA N/A
  • TYGO N/A
  • EPS
  • ZURA N/A
  • TYGO N/A
  • Revenue
  • ZURA N/A
  • TYGO $74,405,000.00
  • Revenue This Year
  • ZURA N/A
  • TYGO $94.76
  • Revenue Next Year
  • ZURA N/A
  • TYGO $23.23
  • P/E Ratio
  • ZURA N/A
  • TYGO N/A
  • Revenue Growth
  • ZURA N/A
  • TYGO 52.31
  • 52 Week Low
  • ZURA $0.97
  • TYGO $0.58
  • 52 Week High
  • ZURA $5.07
  • TYGO $2.75
  • Technical
  • Relative Strength Index (RSI)
  • ZURA 84.19
  • TYGO 82.19
  • Support Level
  • ZURA $2.07
  • TYGO $2.34
  • Resistance Level
  • ZURA $2.35
  • TYGO $2.58
  • Average True Range (ATR)
  • ZURA 0.21
  • TYGO 0.18
  • MACD
  • ZURA 0.20
  • TYGO 0.02
  • Stochastic Oscillator
  • ZURA 95.42
  • TYGO 91.16

About ZURA Zura Bio Limited

Zura Bio Ltd is a clinical-stage, multi-asset immunology company developing novel dual-pathway antibodies for autoimmune and inflammatory diseases. It is developing three assets which have completed Phase I/Ib studies and are Phase II ready. It is developing a portfolio of therapeutic indications for tibulizumab and torudokimab with a goal of demonstrating their efficacy, safety, and dosing convenience in autoimmune and inflammatory diseases.

About TYGO Tigo Energy Inc.

Tigo Energy Inc designs solar power conversion and storage products that provide customers with more choice and flexibility. Its mission is to deliver smart hardware and software solutions that enhance safety, increase energy yield, and lower operating costs of residential, commercial, and utility-scale solar systems. Geographically the company generates revenue from EMEA, Americas, and APAC.

Share on Social Networks: